(Q50949756)

25 March 2018

title

Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. (English)

1 reference

25 March 2018

1 reference

1 reference

1 reference

Shoji T

1

1 reference

25 March 2018

Nishizawa Y

2

1 reference

25 March 2018

Kawagishi T

3

1 reference

25 March 2018

Tanaka M

4

1 reference

25 March 2018

Kawasaki K

5

1 reference

25 March 2018

Tabata T

6

1 reference

25 March 2018

Inoue T

7

1 reference

25 March 2018

Morii H

8

1 reference

25 March 2018

publication date

1 June 1997

1 reference

25 March 2018

published in

Atherosclerosis

1 reference

25 March 2018

volume

131

1 reference

25 March 2018

issue

2

1 reference

25 March 2018

page(s)

229-236

1 reference

25 March 2018

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Accelerated atherosclerosis in prolonged maintenance hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Cardiovascular risk factors in chronic renal failure and hemodialysis populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Lipoprotein metabolism and renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Hypertriglyceridemia. A metabolic consequence of chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Accumulation of lipoprotein remnants in patients with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Increased lipoprotein-remnant formation in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Impaired metabolism of high density lipoprotein in uremic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900054-3

10.1016/S0021-9150(97)00054-3

7 January 2021

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018